Literature DB >> 5305929

[Giant cell tumors (osteoclastomas) of the sellar region].

L Perria, G L Viale, S L Gentile.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5305929     DOI: 10.1007/bf01402260

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  9 in total

1.  Osteoclastoma of the skull.

Authors:  B RAMAMURTHI; G S VISVANATHAN; K M PILLAI
Journal:  J Neurosurg       Date:  1955-05       Impact factor: 5.115

2.  [Giant cell tumors at the base of the skull].

Authors:  O KLEINSASSER; H ALBRECHT
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1958

3.  Giant-cell tumor of the sphenoid bone (osteoclastoma); report of a case.

Authors:  E TARTARINI; A MURATORIO; R CRUDELI
Journal:  Zentralbl Neurochir       Date:  1955

4.  [Cranial tumors].

Authors:  O LEITHOLF
Journal:  Acta Neurochir (Wien)       Date:  1956       Impact factor: 2.216

5.  [So-called brown tumor of the cranium].

Authors:  H MERKEL; H H KLAUE
Journal:  Zentralbl Allg Pathol       Date:  1955-06-20

6.  Giant-cell tumor of bones of the skull; report of two cases.

Authors:  J C McNERNEY
Journal:  J Neurosurg       Date:  1949-03       Impact factor: 5.115

7.  Osteoclastoma in relation to the nose.

Authors:  A B HANDOUSA
Journal:  J Laryngol Otol       Date:  1951-08       Impact factor: 1.469

8.  An osteoclastoma of the skull.

Authors:  G F ROWBOTHAM
Journal:  Br J Surg       Date:  1952-05       Impact factor: 6.939

9.  [Clinical considerations on a case of giant cell sarcoma].

Authors:  G Moscatelli; A Marra
Journal:  Minerva Neurochir       Date:  1965 Jul-Sep
  9 in total
  2 in total

1.  Giant cell tumours of the sellar region.

Authors:  G L Viale
Journal:  Acta Neurochir (Wien)       Date:  1977       Impact factor: 2.216

2.  [Intrasellar chordoma--transphenoidal approach].

Authors:  R Steimlé; H Coudry; G Pageaut; M Mallie; D Comte; G Jacquet
Journal:  Acta Neurochir (Wien)       Date:  1969       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.